Levaquin News
Wockhardt wins FDA tentative approval for antibiotic drug - Trading Markets (press release)
Wockhardt wins FDA tentative approval for antibiotic drugTrading Markets (press release)Levofloxacin is the generic name for the brand Levaquin, marketed in the US by Ortho Mcneil, a subsidiary of Johnson & Johnson. Wockhardt will launch the ...
Three bidders still in fight for Mepha; Genzyme sales dip on manufacturing ... - FiercePharma
Three bidders still in fight for Mepha; Genzyme sales dip on manufacturing ...FiercePharma... Wockhardt got the tentative nod from FDA for marketing various doses of the antibiotic levofloxacin, a generic version of Ortho McNeil's Levaquin. ...Switzerland's Mepha says sale down to three biddersReutersall 6 news articles »
Dumbest PowerPoint Ever? J&J's P&L Slideshow of Alleged Kickback Scheme - BNET
BNETDumbest PowerPoint Ever? J&J's P&L Slideshow of Alleged Kickback SchemeBNETThe DOJ sued J&J alleging that rebates for drugs such as Levaquin were paid to Omnicare (OCR), a pharmacy services company that dominates nursing home care. ...
World Antibacterial Treatments Market 2010-2024 - PRLog.Org (press release)
World Antibacterial Treatments Market 2010-2024PRLog.Org (press release)This market segment contained three blockbuster drugs in 2009: J&J's Levaquin, Tazocin from Wyeth and Pfizer's Zyvox. However, the market for antibacterial ...Research and Markets: Commercial Insight: Antibacterials - Opportunities in ...Earthtimes (press release)all 8 news articles »
Wockhardt gets tentative USFDA nod for Levofloxacin - Moneycontrol.com
Wockhardt gets tentative USFDA nod for LevofloxacinMoneycontrol.comLevofloxacin is the generic name for the brand Levaquin, marketed in the US by Ortho Mcneil. Wockhardt will launch the product immediately upon expiration ...Wockhardt gets US FDA tentative nod for Levofloxacin tabletsEconomic TimesWockhardt gets tentative nod from USFDA for LevofloxacinMyiris.comWockhardt hardens on US nod for a generic drugBloombergUTVRTT News -Myiris.comall 15 news articles »
Earnings Preview: Johnson & Johnson - Seeking Alpha (blog)
MiamiHerald.comEarnings Preview: Johnson & JohnsonSeeking Alpha (blog)Positive drivers for the quarter are expected to come from increasing sales in Remicade, Levaquin and Simponi as well as from medical devices. ...Highlights From JNJ's Q4 Conference Call: Q4 Sales Up 9% Year-over-Year ...StreetInsider.com (subscription)J&J's net declines by 5.3% to $12.3 billion during 2009pharmabiz.comJohnson & Johnson Q4 2009 Earnings Call TranscriptSeeking Alpha (blog)all 320 news articles »
How to raise good cholesterol - Herald & Review
How to raise good cholesterolHerald & ReviewDear Dr. Donohue: Just how dangerous is the drug Levaquin? I read that it should not be given to a person over 60 or to a person with Alzheimer's disease or ...
Johnson and Johnson May Have Used Kickbacks to Increase Sales of Levaquin - Lawyers and Settlements
Lawyers and SettlementsJohnson and Johnson May Have Used Kickbacks to Increase Sales of LevaquinLawyers and SettlementsThe move pushed sales of the antibiotic medication Levaquin to all time highs, even overtaking other leading medications like Cipro over the five year ...US Alleges J&J Gave Kickbacks to Omnicare on Nursing Home DrugsBNETall 2 news articles »
2011년까지 특허만료되는 거대 품목은 어떤 것? - 메디포뉴스
2011년까지 특허만료되는 거대 품목은 어떤 것?메디포뉴스예컨대, 존슨 앤 존슨(J&J)의 레바퀸(Levaquin)은 내년 12월에 특허 만료되지만, 아동용 의약 실험을 위해 6개월 연장되어 시장 독점권은 2011년 6월까지 확대되었다. ...
LegalView Publishes New Info Highlighting Traumatic Brain Injury Breakthrough - PR-USA.net (press release)
LegalView Publishes New Info Highlighting Traumatic Brain Injury BreakthroughPR-USA.net (press release)... dedicated to bringing up to date information on a variety of legal issues, including traumatic brain injuries, Levaquin lawsuits and Vytorin litigation. ...and more »
Levaquin RSS Feed